Samina Khan
SVP, Chief Medical Officer, REATA PHARMACEUTICALS INC.
Companies
- REATA PHARMACEUTICALS INCSVP, Chief Medical Officer Feb 7, 2022 to May 17, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- REATA PHARMACEUTICALS INC39,491 shares2May 16, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- May 16, 2023Sold 352 shares at $81.37 of REATA PHARMACEUTICALS INC2
- May 15, 2023Sold 288 shares at $85.32 of REATA PHARMACEUTICALS INC2
- Mar 7, 2023Sold 3,961 shares at $83.46 of REATA PHARMACEUTICALS INC3
- Mar 3, 2023Sold 2,813 shares at $87.36 of REATA PHARMACEUTICALS INC4
- Mar 2, 2023Sold 2,649 shares at $85.38 of REATA PHARMACEUTICALS INC4
- Mar 2, 2023Sold 18,956 shares at $85.02 of REATA PHARMACEUTICALS INC4
- Mar 2, 2023Sold 3,395 shares at $83.70 of REATA PHARMACEUTICALS INC4
- Mar 2, 2023Exercised options 25,000 shares at $27.32 of REATA PHARMACEUTICALS INC4
- Jan 3, 2023Granted 11,756 shares of REATA PHARMACEUTICALS INC5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 8, 2023
- 4SEC EDGARForm 4 filed Mar 6, 2023
- 5SEC EDGARForm 4 filed Jan 4, 2023